One thing I don't understand: he said he 'bought clinical trials'. What does that mean?
Imho, the main thing that prevented this product from being useful was the lack of evidence that using it actually improves treatment outcomes compared to what doctors/patients already do. If he could have pointed to studies showing this, the doctors might have reacted differently. Even better, if he could have used his fancy statistics to create personalized recommendations and then demonstrated that they improve outcomes, he might have been on to something. The current tool was optimizing for the average patient, but nowadays we want personalized medicine.
Imho, the main thing that prevented this product from being useful was the lack of evidence that using it actually improves treatment outcomes compared to what doctors/patients already do. If he could have pointed to studies showing this, the doctors might have reacted differently. Even better, if he could have used his fancy statistics to create personalized recommendations and then demonstrated that they improve outcomes, he might have been on to something. The current tool was optimizing for the average patient, but nowadays we want personalized medicine.